We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rectangle Image
News

Metabolon and Dian Open New Metabolomics Laboratory in China

Rectangle Image
News

Metabolon and Dian Open New Metabolomics Laboratory in China

Read time:
 
Metabolon, Inc., the global leader in metabolomics, announced that its joint metabolomics laboratory with Zhejiang Dian Diagnostics Co., Ltd., one of China's largest chains of independent medical laboratories, has achieved full validation in running Metabolon's proprietary metabolomics platform. The joint laboratory is located in Hangzhou and has started processing client samples under an exclusive licensing agreement with Metabolon announced in February 2017. Hangzhou Calibra Diagnostics Co., Ltd., a majority-owned subsidiary of DIAN, will be the exclusive partner for providing Metabolon's metabolomics services and commercializing its technology in China.

"Launching our global metabolomics platform in China allows us to better serve current and future customers in this significant, growing market," said Metabolon CEO John Ryals, PhD. "Calibra has done an outstanding job establishing the laboratory, validating the platform and preparing its marketing team for this day. We look forward to a successful relationship as they expand our service offerings for research applications in clinical research, health management, traditional Chinese medicine, pharmaceuticals, consumer goods and agriculture, as well as supporting large-cohort population studies throughout the Chinese market.

"Calibra is pleased to exclusively offer Metabolon's technology in China, and I am confident that our collaboration is going to open many new opportunities to help advance metabolomics applications in this market," said Hua-fen Liu, Calibra CEO.

Metabolon's technology screens the largest, most diverse metabolite reference library in the industry and leverages proprietary software and biochemistry expertise to deliver the most accurate and comprehensive metabolomics data. This data can be used by life sciences researchers to gain actionable biological insight and understand genomic and other -omics data.
Advertisement